Abstract. The aim of the present study was to predict key genes and proteins associated with complex regional pain syndrome (CRPS) using bioinformatics analysis. The gene expression profiling microarray data, GSE47603, which included peripheral blood samples from 4 patients with CRPS and 5 healthy controls, was obtained from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) in CRPS patients compared with healthy controls were identified using the GEO2R online tool. Functional enrichment analysis was then performed using The Database for Annotation Visualization and Integrated Discovery online tool. Protein-protein interaction (PPI) network analysis was subsequently performed using Search Tool for the Retrieval of Interaction Genes database and analyzed with Cytoscape software. A total of 257 DEGs were identified, including 243 upregulated genes and 14 downregulated ones. Genes in the human leukocyte antigen (HLA) family were most significantly differentially expressed. Enrichment analysis demonstrated that signaling pathways, including immune response, cell motion, adhesion and angiogenesis were associated with CRPS. PPI network analysis revealed that key genes, including early region 1A binding protein p300 (EP300), CREB-binding protein (CREBBP), signal transducer and activator of transcription (STAT)3, STAT5A and integrin α M were associated with CRPS. The results suggest that the immune response may therefore serve an important role in CRPS development. In addition, genes in the HLA family, such as HLA-DQB1 and HLA-DRB1, may present potential biomarkers for the diagnosis of CRPS. Furthermore, EP300, its paralog CREBBP, and the STAT family genes, STAT3 and STAT5 may be important in the development of CRPS.
Introduction
Complex regional pain syndrome (CRPS) is an uncommon chronic pain condition that develops following trauma. The features include limb pain, allodynia, hypersensitivity, motor abnormality and trophic alterations (1) . Women are affected more commonly than men, and postmenopausal women demonstrate the highest risk (2) . CRPS is classified into two subtypes depending on the presence of peripheral nerve injury. CRPS type I without peripheral nerve injury is more common than type II, which presents as peripheral nerve injury (3) . In addition, CRPS is categorized into 'warm' or 'cold' CRPS depending on whether skin temperature is increased or decreased (4) . Although CRPS is designated as an orphan disease in the general population, it affects ~4-7% patients experiencing limb fractures (5) . CRPS is a burden on the healthcare system and society. A number of different therapeutic strategies have been applied to treat CRPS, including pharmacological, interventional and psychological methods; however, there evidence to support their efficiency of these methods is insufficient (5) . The pathogenesis of CRPS is unclear (6) , however several mechanisms have are thought to be involved, including inflammation, neurogenic inflammation and alterations of the central nerve system (6) . Goebel et al (7) elucidated the association between inflammation, immune response and CRPS, and an autoimmune model was proposed. Oaklander et al (8) proposed that CRPS is associated with distal degeneration of small diameter peripheral axons. Barad et al (9) demonstrated that brain structure was involved in CRPS. However, little is known about how these mechanisms interact to lead to CRPS. Therefore, identifying key genes or signaling pathways involved in the development of CRPS may facilitate elucidation of the integrated mechanism of CRPS and enable the development of targeted therapies.
Genome-wide expression profiling of CPRS was recently performed by Jin et al (10) . The authors collected and analyzed peripheral blood examples from healthy controls and patients with CRPS. Differentially expressed genes (DEGs)
were identified using microarray analysis, and out of those identified, 6 genes were selected for further confirmation by reverse transcription-quantitative polymerase chain reaction analysis. The authors focused on a significantly upregulated DEG (matrix metallopeptidase 9), thought to be associated with pain progression in CRPS. However, the gene/protein interaction networks involved in CRPS remain unknown, which is necessary to elucidate how inflammation, neurogenic inflammation and alterations of the central nervous system are involved in CRPS. Therefore, the authors of the present study constructed a protein-protein interaction network in order to identify the specific molecular interactions involved in CRPS.
In the present study, the GSE47603 gene expression profiling microarray data deposited by Jin et al (10) was obtained and used to identify CRPS-associated genes in patients with CRPS. The microarray data was used to identify key DEGs associated with CRPS by employing comprehensive analysis methods in order to enrich the functions and signaling pathways of identified DEGs. In addition, a protein-protein interaction (PPI) network was constructed and analyzed to identify hub genes. The aim of the current study was to identify several key genes associated with the disease, and examine their potential function in the development of CRPS by expression profile analysis. The results may facilitate the identification of potential targets for the diagnosis and treatment of CRPS.
Materials and methods
Microarray data. The GSE47603 microarray data, deposited by Jin et al (10) was obtained from the Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo). This microarray used the GPL10558 platform (Illumina HumanHT-12 v4 expression beadchip; Illumina, Inc., San Diego, CA, USA). A total of 9 peripheral blood samples from 4 patients with CRPS and 5 healthy controls were included in the genome-wide expression profiling array, as described previously (10) . Out of the patients with CRPS, 2 patients presented with CRPS type I and 2 patients presented with CRPS type II. Patients who received medication of CRPS were included; however, those with additional neurogenic disorders caused by this medication were excluded. The control subjects did not present with infectious disease, pain disorders and had not undergone recent surgery.
Data processing. Array data export, processing and analysis was performed using the Gene Expression Module (version, 1.9.0) of Illumina GenomeStudio software (version, 2011.1; Illumina, Inc.). Data were already quantile-normalized. Significant DEGs were identified by comparing profile data from patients with CRPS with that of control subjects using the online analysis tool, GEO2R To analyze the putative functions of identified DEGs, GO annotation associated with BP and KEGG pathway enrichment analyses were performed using the online DAVID tool version 6.7 (11, 12) . A P-value of <0.05 and gene counts of >2 were considered to be significant.
PPI construction. The Search Tool for the Retrieval of
Interaction Genes (STRING; http://string.embl.de/) database collects comprehensive information regarding predicted and experimental interactions between proteins in a given cell. In the present study, DEGs were mapped in the STRING database version, 10.0 (13) to construct a PPI network, which provides an improved understanding of the functional organization of the proteome. A combined score of >4 was set as the threshold. The PPI network was subsequently analyzed using Cytoscape (http://www.cytoscape.org/, version, 3.3.0) software. The degree of connectivity of each node in the PPI network was calculated, and the hub nodes were identified. Genes were clustered using the MCODE Cytoscape plugin (version, 1.4.1).
Results

DEG analysis.
Using adjusted P-values of <0.05 and FC values of >1.5, a total of 257 DEGs were identified in blood samples from patients with CRPS when compared with the controls. This included 243 upregulated and 14 downregulated genes (Tables I and II) . The most significantly upregulated and downregulated genes were human leukocyte antigen (HLA)-DRB1 and HLA-DQB1, respectively, which belong to the HLA family. An additional member of the HLA family, HLA-DRB4, was significantly downregulated in CRPS samples when compared with controls (Table II) .
Functional enrichment analysis. The over-represented GO-BP terms of DEGs were primarily associated with antigen processing and presentation, the immune response process, the integrin-mediated signaling pathway, cell motion and adhesion, angiogenesis, and cell-substrate junction assembly (Table III) . In addition, DEGs were enriched in KEGG pathways including viral myocarditis, systemic lupus erythematosus, asthma, allograft rejection, graft-vs.-host disease, type I diabetes mellitus, intestinal immune network for immunoglobulin A production, autoimmune thyroid disease, antigen processing and presentation and hematopoietic cell lineage (Table IV) .
PPI analysis. The PPI network generated using the STRING database included 155 nodes and 400 edges (Fig. 1) . Topological structure analysis performed by Cytoscape software revealed the degree of genes in the PPI network. Nodes with a higher degree are more connected with other nodes, and they are considered to contribute to the stability of the network and are designated as hub nodes. In the present study, genes with a higher degree included adenovirus early region 1A binding protein p300 (EP300), CREB-binding protein (CREBBP), signal transducer and activator of transcription (STAT)3 and STAT5A of the STAT protein family, interleukin 8 (IL8) and integrin α M (ITGAM).
A total of 3 modules with a score of >4 were identified using the MCODE plugin (Fig. 2) . Cluster 1 exhibited the highest score, and DEGs, such as EP300, CREBBP, STAT3, STAT5A and ITGAM were included. Enrichment analysis demonstrated that the GO-BP terms enriched by these genes were associated with regulation of transcription, biosynthesis, hormone stimuli responses and cell differentiation (Table V) . DEGs in cluster 2 primarily included ITGAM, retinoic acid receptor α, integrin subunit α 2B and DNA-directed RNA polymerase II subunit RPB1 (Fig. 2) , which were enriched Benjamini and Hochberg's false discovery rate was applied to adjust the P-value. FC, fold-change.
in GO-BP terms associated with cell adhesion and apoptosis (Table V) . DEGs in cluster 3 included C5 anaphylatoxin chemotactic receptor 1, GPR18, hydroxycarboxylic acid receptor (HCAR) 2 and HCAR3 (Fig. 2 ), which were enriched in the G-protein signaling pathway (Table V) .
Discussion
In the present study, a total of 257 DEGs were identified in blood samples from patients with CRPS when compared with healthy controls. Pathway enrichment analysis demonstrated that the identified DEGs were primarily enriched in immune response, cell motion, adhesion and angiogenesis signaling pathways. In the PPI network, EP300 displayed the highest degree and was present in cluster 1. Additional DEGs in cluster 1 with relatively high degrees were STAT3, CREBBP, STAT5A, ITGAM, notch homolog 1, CCAAT/enhancer binding protein β and mitogen-activated protein kinase 3.
Goebel et al (14) demonstrated that intravenous immunoglobulin (IVIG) is effective for the reduction of pain in patients with CRPS, which suggests that the immune response may be important in the development of CRPS. Subsequent studies indicated that neuroautoimmunity and neurogenic inflammation contribute to CRPS. Cooper et al (15) demonstrated that infiltrating leukocytes reacted to autoantibodies that bind to autoantigens located on the surface of neuronal and glial cell targets, and were closely associated with neuroautoimmune responses. In addition, the development of autoantibodies against the β 2 adrenergic receptor and muscarinic-2 receptor were identified in patients with CRPS (16). HLA-DQB1, HLA-DRB4 and HLA-DRB1, which belong to class II of the HLA family, are expressed by a subgroup of immune cells, including B cells, activated T cells and macrophages (17) . Kemler et al (18) discovered increased expression of HLA-DQB1 among CRPS patients. In addition, a previous study demonstrated that HLA is associated with CRPS whereby two members of the HLA family (HLA-DQ8 and HLA-B62) were observed to be differentially expressed in different subtypes of CRPS (19) . Furthermore, genes in class I of the HLA family were observed to be associated with the development of CRPS (20) . HLA-DR2 and HLA-DR13 have been reported to be associated with CRPS (21, 22) . However, studies in HLA-DRB4 and DRB1 have not focused on their roles in CRPS. Therefore, further research to determine how HLA may be involved in CRPS may provide additional important information. Changes in the expression levels of the HLA family indicates that CRPS may be associated with inflammation regulation (19) . Additionally, CRPS may be important to genes closely associated with HLA instead of HLA genes themselves (20) . EP300 and its paralog CREBBP are transcriptional coactivators that regulate gene transcription by connecting DNA-binding and transcription factors, relaxing chromatin through its intrinsic histone acetyltransferase activity and modifying specific transcription factors (23) . EP300 and CREBBP have been implicated in a large number of diseases. Lunning et al (24) demonstrated that mutations in EP300 and CREBBP are present in germinal center B-cell lymphomas. Kishimoto et al (25) demonstrated that EP300 and CREBBP may be involved in the pathogenesis of follicular lymphoma. Notably, Seltzer et al (26) indicated that EP300 and CREBBP were associated with postnatal microcephaly. That EP300 and CREBBP have a high degree in the PPI network found by our study may add to the myriad of roles of EP300 and CREBBP in disease.
STAT3 and STAT5 belong to the STAT protein family, which was first discovered as part of the cytokine signaling pathway (27) . These proteins demonstrate a significant effect on the immune response and in the process of oncogenesis (27) . STAT3A serves multiple roles in cytokine signaling pathways (27) . STAT3-knock out mice were incapable of completing gastrulation (28) , and conditional STAT3-knock out promotes apoptosis (29) . In addition, STAT3 is involved in the differentiation of CD4 + cells to Th17 cells, which protect against invading bacteria and fungi and are involved in the autoimmune response (30, 31) . Furthermore, STAT3 is a recognized oncogene (32) . Similarly, STAT5 serves an important role in the differentiation of CD4 + cells into Treg cells, which are involved in reducing the immune response and protecting against autoimmune disease (31, 33) . STAT5 expression deficiency was found to closely associated with tumorigenesis by changing the function of natural killer cells to tumor promotion (34) . This implies that STAT may be the potential therapeutic target for CRPS (31) .
In conclusion, the results of the present study provided additional evidence in support of the hypothesis that neuroautoimmunity is an important factor for the pathogenesis of CRPS. And significant genes such as HLA-DQB1, HLA-DRB4, HLA-DRB1 from the HLA family, EP300 and its paralog CREBBP, STAT3 and STAT5 from the STAT family were identified by differentially expressed gene and topological analyses, and module identification of the PPI network constructed from these genes. However, further experiments such as western blotting are required to confirm the changes of expression levels of these genes. Additionally, to fully elucidate the mechanism behind how change in the expression levels of these genes lead to CRPS, further studies are required to determine, which pathways contribute to CRPS. Due to the small sample size of the present study the current findings are limited. Therefore, pooling CRPS samples from different sources in future investigations will increase the sample size and confirm the current findings.
